Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells

dc.authoridgumus, nurcan/0000-0001-9989-4590
dc.authoridTezcanli KAYMAZ, Burcin/0000-0003-1832-1454
dc.authoridCelik, Besne/0000-0001-5417-8005
dc.authoridAvci, Cigir Biray/0000-0001-8251-4520
dc.contributor.authorTezcanli Kaymaz, Burcin
dc.contributor.authorGumus, Nurcan
dc.contributor.authorCelik, Besne
dc.contributor.authorAlcitepe, Ilayda
dc.contributor.authorBiray Avci, Cigir
dc.contributor.authorAktan, Cagdas
dc.date.accessioned2025-03-09T10:48:53Z
dc.date.available2025-03-09T10:48:53Z
dc.date.issued2024
dc.departmentİstanbul Beykent Üniversitesi
dc.description.abstractChronic myeloid leukemia (CML) is a clonal myeloproliferative hematological disease characterized by the chimeric breakpoint-cluster region/Abelson kinase1 (BCR
dc.identifier.doi10.1089/jir.2023.0170
dc.identifier.endpage189
dc.identifier.issn1079-9907
dc.identifier.issn1557-7465
dc.identifier.issue4
dc.identifier.pmid38579140
dc.identifier.scopus2-s2.0-85190333642
dc.identifier.scopusqualityQ3
dc.identifier.startpage178
dc.identifier.urihttps://doi.org/10.1089/jir.2023.0170
dc.identifier.urihttps://hdl.handle.net/20.500.12662/4680
dc.identifier.volume44
dc.identifier.wosWOS:001197190100002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofJournal of Interferon and Cytokine Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250310
dc.subjectponatinib
dc.subjectcombination therapy
dc.subjectcytokines
dc.subjectSTAT5 inhibitor pimozide
dc.subjectdrug resistance
dc.titlePonatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells
dc.typeArticle

Dosyalar